What it is
Regulatory status: FDA-cleared chambers and medical oxygen are used for specific conditions; broad anti-aging or longevity use is not an established UHMS indication.
Mechanism evidence: human
Increased ambient pressure raises dissolved oxygen in plasma and tissue oxygen delivery. This can support selected hypoxic or wound-healing conditions, but exposure pressure, oxygen dose, session duration and clinical indication materially change the risk-benefit balance.
What it is, why people use it, the evidence, and what to know before trying it.
Regulatory status: FDA-cleared chambers and medical oxygen are used for specific conditions; broad anti-aging or longevity use is not an established UHMS indication.
Mechanism evidence: human
HBOT is evidence-based for a defined set of medical indications. Bryan Johnson's 60-session longevity experiment is outside those established indications, and biomarker findings do not show longer life or better clinical outcomes.
Confidence: strong
Situations where this practice may need modification or professional guidance.
Common risks include ear or sinus barotrauma, temporary vision changes and oxygen-related symptoms. Rare but serious risks include oxygen seizures, lung injury, fire and chamber accidents. Untreated pneumothorax is a contraindication; treatment belongs in an accredited medical program with trained staff.
This review does not automatically apply to:
Public protocols that include Hyperbaric oxygen therapy. Open one to see the full context and source.
Reviewed session and timing context, separate from what public protocols report.
Session and schedule patterns reported in public protocols; these are observations, not instructions. Private and hidden usage is excluded.
Continue into interventions that appear alongside this one.